673 related articles for article (PubMed ID: 22247441)
1. Pathogenesis of mucormycosis.
Ibrahim AS; Spellberg B; Walsh TJ; Kontoyiannis DP
Clin Infect Dis; 2012 Feb; 54 Suppl 1(Suppl 1):S16-22. PubMed ID: 22247441
[TBL] [Abstract][Full Text] [Related]
2. Bicarbonate correction of ketoacidosis alters host-pathogen interactions and alleviates mucormycosis.
Gebremariam T; Lin L; Liu M; Kontoyiannis DP; French S; Edwards JE; Filler SG; Ibrahim AS
J Clin Invest; 2016 Jun; 126(6):2280-94. PubMed ID: 27159390
[TBL] [Abstract][Full Text] [Related]
3. The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis.
Ibrahim AS; Gebremariam T; Lin L; Luo G; Husseiny MI; Skory CD; Fu Y; French SW; Edwards JE; Spellberg B
Mol Microbiol; 2010 Aug; 77(3):587-604. PubMed ID: 20545847
[TBL] [Abstract][Full Text] [Related]
4. Host cell invasion in mucormycosis: role of iron.
Ibrahim AS
Curr Opin Microbiol; 2011 Aug; 14(4):406-11. PubMed ID: 21807554
[TBL] [Abstract][Full Text] [Related]
5. GRP78 and Integrins Play Different Roles in Host Cell Invasion during Mucormycosis.
Alqarihi A; Gebremariam T; Gu Y; Swidergall M; Alkhazraji S; Soliman SSM; Bruno VM; Edwards JE; Filler SG; Uppuluri P; Ibrahim AS
mBio; 2020 Jun; 11(3):. PubMed ID: 32487760
[TBL] [Abstract][Full Text] [Related]
6. Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis.
Gebremariam T; Alkhazraji S; Soliman SSM; Gu Y; Jeon HH; Zhang L; French SW; Stevens DA; Edwards JE; Filler SG; Uppuluri P; Ibrahim AS
Sci Adv; 2019 Jun; 5(6):eaaw1327. PubMed ID: 31206021
[TBL] [Abstract][Full Text] [Related]
7. The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice.
Liu M; Spellberg B; Phan QT; Fu Y; Fu Y; Lee AS; Edwards JE; Filler SG; Ibrahim AS
J Clin Invest; 2010 Jun; 120(6):1914-24. PubMed ID: 20484814
[TBL] [Abstract][Full Text] [Related]
8. CotH3 mediates fungal invasion of host cells during mucormycosis.
Gebremariam T; Liu M; Luo G; Bruno V; Phan QT; Waring AJ; Edwards JE; Filler SG; Yeaman MR; Ibrahim AS
J Clin Invest; 2014 Jan; 124(1):237-50. PubMed ID: 24355926
[TBL] [Abstract][Full Text] [Related]
9. Host-iron assimilation: pathogenesis and novel therapies of mucormycosis.
Ibrahim AS
Mycoses; 2014 Dec; 57 Suppl 3(0 3):13-7. PubMed ID: 25178879
[TBL] [Abstract][Full Text] [Related]
10. Effects of iron and desferrioxamine on Rhizopus infection.
Abe F; Inaba H; Katoh T; Hotchi M
Mycopathologia; 1990 May; 110(2):87-91. PubMed ID: 2142253
[TBL] [Abstract][Full Text] [Related]
11. Fob1 and Fob2 Proteins Are Virulence Determinants of Rhizopus oryzae via Facilitating Iron Uptake from Ferrioxamine.
Liu M; Lin L; Gebremariam T; Luo G; Skory CD; French SW; Chou TF; Edwards JE; Ibrahim AS
PLoS Pathog; 2015 May; 11(5):e1004842. PubMed ID: 25974051
[TBL] [Abstract][Full Text] [Related]
12. Primary Cutaneous Mucormycosis Caused by Rhizopus oryzae: A Case Report and Review of Literature.
Rodríguez-Lobato E; Ramírez-Hobak L; Aquino-Matus JE; Ramírez-Hinojosa JP; Lozano-Fernández VH; Xicohtencatl-Cortes J; Hernández-Castro R; Arenas R
Mycopathologia; 2017 Apr; 182(3-4):387-392. PubMed ID: 27807669
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary mucormycosis.
Hamilos G; Samonis G; Kontoyiannis DP
Semin Respir Crit Care Med; 2011 Dec; 32(6):693-702. PubMed ID: 22167397
[TBL] [Abstract][Full Text] [Related]
14. How does antifungal pharmacology differ for mucormycosis versus aspergillosis?
Lewis RE; Lortholary O; Spellberg B; Roilides E; Kontoyiannis DP; Walsh TJ
Clin Infect Dis; 2012 Feb; 54 Suppl 1():S67-72. PubMed ID: 22247448
[TBL] [Abstract][Full Text] [Related]
15. Deferiprone iron chelation as a novel therapy for experimental mucormycosis.
Ibrahim AS; Edwards JE; Fu Y; Spellberg B
J Antimicrob Chemother; 2006 Nov; 58(5):1070-3. PubMed ID: 16928702
[TBL] [Abstract][Full Text] [Related]
16. Lactoferrin, a potential iron-chelator as an adjunct treatment for mucormycosis - A comprehensive review.
Singh A; Ahmad N; Varadarajan A; Vikram N; Singh TP; Sharma S; Sharma P
Int J Biol Macromol; 2021 Sep; 187():988-998. PubMed ID: 34324905
[TBL] [Abstract][Full Text] [Related]
17. Future directions in mucormycosis research.
Kontoyiannis DP; Lewis RE; Lortholary O; Spellberg B; Petrikkos G; Roilides E; Ibrahim A; Walsh TJ
Clin Infect Dis; 2012 Feb; 54 Suppl 1(Suppl 1):S79-85. PubMed ID: 22247450
[TBL] [Abstract][Full Text] [Related]
18. Mucormycosis in diabetic ketoacidosis. Role of unbound iron binding capacity of transferrin.
Abe F; Shibuya H; Tateyama M; Ommura Y; Azumi N; Kimura K
Acta Pathol Jpn; 1986 Oct; 36(10):1507-12. PubMed ID: 3099540
[TBL] [Abstract][Full Text] [Related]
19. A closer look at pathogenesis of cerebral mucormycosis in diabetic condition: A mini review.
Khoshbayan A; Didehdar M; Chegini Z; Taheri F; Shariati A
J Basic Microbiol; 2021 Mar; 61(3):212-218. PubMed ID: 33448040
[TBL] [Abstract][Full Text] [Related]
20. Pathways of Pathogenicity: Transcriptional Stages of Germination in the Fatal Fungal Pathogen
Sephton-Clark PCS; Muñoz JF; Ballou ER; Cuomo CA; Voelz K
mSphere; 2018 Sep; 3(5):. PubMed ID: 30258038
[No Abstract] [Full Text] [Related]
[Next] [New Search]
